<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:department>Psychiatry</gtr:department><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/8CB2FBAC-797E-4A4C-9B42-3B343A0266D6"><gtr:id>8CB2FBAC-797E-4A4C-9B42-3B343A0266D6</gtr:id><gtr:firstName>Guy</gtr:firstName><gtr:surname>Goodwin</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/19D1396C-ECFC-4111-9838-02133E0C97EF"><gtr:id>19D1396C-ECFC-4111-9838-02133E0C97EF</gtr:id><gtr:firstName>Paul</gtr:firstName><gtr:surname>Harrison</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/D1C5947D-8FD1-4F79-A0C9-C0432A8D2B38"><gtr:id>D1C5947D-8FD1-4F79-A0C9-C0432A8D2B38</gtr:id><gtr:firstName>Alastair</gtr:firstName><gtr:otherNames>McIntosh</gtr:otherNames><gtr:surname>Gray</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/90E1AFC0-E4B9-451F-8D52-80F0D6033F87"><gtr:id>90E1AFC0-E4B9-451F-8D52-80F0D6033F87</gtr:id><gtr:firstName>Edmund</gtr:firstName><gtr:surname>Juszczak</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/AB9A1DD7-6E64-4042-9440-5CA9F064300A"><gtr:id>AB9A1DD7-6E64-4042-9440-5CA9F064300A</gtr:id><gtr:firstName>John</gtr:firstName><gtr:otherNames>Richard</gtr:otherNames><gtr:surname>Geddes</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/C01830E9-C634-4F6E-A163-AC0AE4DC2489"><gtr:id>C01830E9-C634-4F6E-A163-AC0AE4DC2489</gtr:id><gtr:firstName>Jennifer</gtr:firstName><gtr:otherNames>Mary</gtr:otherNames><gtr:surname>Rendell</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0700477"><gtr:id>4F1F4E33-4B67-446B-954B-56C565C077A4</gtr:id><gtr:title>CEQUEL-FA: Comparative evaluation of quetiapine plus lamotrigine vs quetiapine monotherapy, and folic acid vs placebo</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0700477</gtr:grantReference><gtr:abstractText>People with bipolar depression have considerable unmet treatment needs whcih means that they often suffer from continuing symptoms and disability. For the first time, promising drug treatments are now emerging, but we need to know how they can best ben used to help people. We will do a randomised clinical trial investigating the combination of quetiapine and lamotrigine which will help clinicians and patients to choose the best treatment for depressive symptoms in bipolar disorder. We will also investigate the possibility that folic acid - a naturally occurring vitamin - will improve symptoms</gtr:abstractText><gtr:technicalSummary>CEQUEL-FA is a randomised controlled trial investigating the efficacy of combination lamotrigine plus quetiapiane in people with bipolar depression. The trial is a 2x2 factorial design with patients additionally being randomised to folic acid or placebo. The trial outcomes are remission from depressive symptoms at 12 weeks and maintenance of improvement by 12 months. A number of secondary analyses will be conducted which should yield valuable knowledge about the neurobiology of folic acid in mood disorders.

The results of CEQUEL-FA will guide therapy for people with bipolar disorder for many years to come and will inform the development of future clinical practice guidelines</gtr:technicalSummary><gtr:fund><gtr:end>2012-09-30</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2007-10-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>1716036</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Radio and newspaper interviews</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>B65EE016-AB5D-4D04-A9B8-F285DC831499</gtr:id><gtr:impact>Several radio interviews

Generated further interest in public</gtr:impact><gtr:outcomeId>54646f40885a07.15158247</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>Pre-2006,2006,2007,2008,</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Post-graduate lecture</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>9C2E6B14-CCBE-4965-AFC3-5FEE2C1553C8</gtr:id><gtr:impact>Lecture plus questions on contect and design of research

Recruited investigators Changed clinical practice</gtr:impact><gtr:outcomeId>3E6F4E0CF82</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2007,2008,2009</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>418829</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Research Grant (HSPHRB)</gtr:description><gtr:end>2009-02-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>7B68B992-5CA1-44EE-81BC-10CEA43253BA</gtr:id><gtr:outcomeId>34F3556508B0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-02-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1580921</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>NIHR Programme Grants for Applied Research</gtr:description><gtr:end>2015-06-02</gtr:end><gtr:fundingOrg>National Institute for Health Research</gtr:fundingOrg><gtr:id>4BF06636-9FCB-4880-A10D-A808580541EC</gtr:id><gtr:outcomeId>VEqFYYTt1kY</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2009-03-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1470000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Strategic Awards</gtr:description><gtr:end>2016-04-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:fundingRef>102616/Z/13/Z</gtr:fundingRef><gtr:id>6BD5D397-DC6C-428F-BFC9-0440F49553E9</gtr:id><gtr:outcomeId>e73x8NSrw6W</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2014-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1000000</gtr:amountPounds><gtr:country>Global</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Stanley Medical Research Institute (SMRI)</gtr:description><gtr:end>2012-04-02</gtr:end><gtr:fundingOrg>Stanley Medical Research Institute (SMRI)</gtr:fundingOrg><gtr:id>F2DD0AF4-CAF0-485C-B717-7D7F11343045</gtr:id><gtr:outcomeId>CX6oA3VQf2k0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2009-03-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Course on RCTs</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>1607C3DA-1358-40D1-B6D2-566498E66343</gtr:id><gtr:impact>Regular course in collaboration with Centre for Statistics in Medicine, NPEU and UK Cochrane Centre</gtr:impact><gtr:outcomeId>drmgn8Z7XeP</gtr:outcomeId><gtr:type>Influenced training of practitioners or researchers</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>OSCHR Review of Mental Health Research</gtr:description><gtr:geographicReach>UK</gtr:geographicReach><gtr:id>E09AE09E-DF0F-47D4-BB26-59171285DB66</gtr:id><gtr:impact>Impact on research strategy</gtr:impact><gtr:outcomeId>h3diav2bxmt</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs><gtr:productOutput><gtr:clinicalTrial>true</gtr:clinicalTrial><gtr:description>True Colours is an online self-management system that allows the patient to monitor symptoms and experiences using text, email and the internet. By answering questionnaires the patient creates a record of how they are feeling and can see how it changes over time. True Colours can be used help self-manage health and to share information with family, friends or care team. Data are stored on a secure computer system.</gtr:description><gtr:id>85580140-2BCB-4EC7-990B-91D6F1617AD6</gtr:id><gtr:impact>New system for capturing PROMS that is being deployed throughout Oxford and via Oxford AHSN and AHSC</gtr:impact><gtr:outcomeId>pzprofh3UQu</gtr:outcomeId><gtr:stage>Early clinical assessment</gtr:stage><gtr:status>Under active development/distribution</gtr:status><gtr:title>True Colours</gtr:title><gtr:type>Support Tool - For Medical Intervention</gtr:type><gtr:ukcrnIsctnId>67300357</gtr:ukcrnIsctnId><gtr:url>https://truecolours.nhs.uk/www/</gtr:url><gtr:yearDevCompleted>2013</gtr:yearDevCompleted></gtr:productOutput></gtr:productOutputs><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>We have validated the method of capturing the primary outcome using text messages - this has now been implemented in the NHS for routine collection of outcomes.</gtr:description><gtr:id>95F75AB0-50A0-40A5-B37D-C46A5225B898</gtr:id><gtr:impact>Won national NHS Live prize for innovation 2008</gtr:impact><gtr:outcomeId>9B1301D3688</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>SMS outcome assessment</gtr:title><gtr:type>Database/Collection of Data/Biological Samples</gtr:type><gtr:yearFirstProvided>2008</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>4969FF06-A724-4F96-8876-2AD9476D9259</gtr:id><gtr:title>A systematic review and economic model of the clinical effectiveness and cost-effectiveness of interventions for preventing relapse in people with bipolar disorder.</gtr:title><gtr:parentPublicationTitle>Health technology assessment (Winchester, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3959d31458803feed987d7b7b078b549"><gtr:id>3959d31458803feed987d7b7b078b549</gtr:id><gtr:otherNames>Soares-Weiser K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1366-5278</gtr:issn><gtr:outcomeId>8B78131A292</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1DC0F8F0-20D3-4699-9A66-DA61A943D452</gtr:id><gtr:title>Oxcarbazepine in the maintenance treatment of bipolar disorder.</gtr:title><gtr:parentPublicationTitle>The Cochrane database of systematic reviews</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/47420ead4d7d782171722e536a813495"><gtr:id>47420ead4d7d782171722e536a813495</gtr:id><gtr:otherNames>Vasudev A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1361-6137</gtr:issn><gtr:outcomeId>2ACD76C9D73</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6EDBA924-4425-47F2-9937-5EF51BAE68ED</gtr:id><gtr:title>Risperidone in long-term treatment for bipolar disorder.</gtr:title><gtr:parentPublicationTitle>The Cochrane database of systematic reviews</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fb71107ddc2eef940683ba1afc8e5128"><gtr:id>fb71107ddc2eef940683ba1afc8e5128</gtr:id><gtr:otherNames>Rendell JM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1361-6137</gtr:issn><gtr:outcomeId>7403422B218</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8A8C1CE9-41D8-4097-8CDE-7D301DEED5AD</gtr:id><gtr:title>Comparison of carbamazepine and lithium in treatment of bipolar disorder: a systematic review of randomized controlled trials.</gtr:title><gtr:parentPublicationTitle>Human psychopharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/aef8b721206d476af68a8daaa7ddce3a"><gtr:id>aef8b721206d476af68a8daaa7ddce3a</gtr:id><gtr:otherNames>Ceron-Litvoc D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0885-6222</gtr:issn><gtr:outcomeId>826FD07167D</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2E48D118-D4AC-42FB-9D64-B2E4F4AA0EDA</gtr:id><gtr:title>Lithium plus valproate combination therapy versus monotherapy for relapse prevention in bipolar I disorder (BALANCE): a randomised open-label trial.</gtr:title><gtr:parentPublicationTitle>Lancet (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f97a3edbc2dff06b8d4def610c24a063"><gtr:id>f97a3edbc2dff06b8d4def610c24a063</gtr:id><gtr:otherNames>BALANCE investigators and collaborators</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0140-6736</gtr:issn><gtr:outcomeId>EsifT29ncV2</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>508B99DC-FE0B-432A-B83E-49AF39AD153D</gtr:id><gtr:title>Mental imagery as an emotional amplifier: application to bipolar disorder.</gtr:title><gtr:parentPublicationTitle>Behaviour research and therapy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/729b6dde35521ec756826acf8e5a9d36"><gtr:id>729b6dde35521ec756826acf8e5a9d36</gtr:id><gtr:otherNames>Holmes EA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0005-7967</gtr:issn><gtr:outcomeId>a9Ehwkh8faQ</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9860D3EB-F329-4093-B238-66293E59310F</gtr:id><gtr:title>Neuropsychological testing of cognitive impairment in euthymic bipolar disorder: an individual patient data meta-analysis.</gtr:title><gtr:parentPublicationTitle>Acta psychiatrica Scandinavica</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f93c3df7fce8d60fe452b781bff6c419"><gtr:id>f93c3df7fce8d60fe452b781bff6c419</gtr:id><gtr:otherNames>Bourne C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0001-690X</gtr:issn><gtr:outcomeId>pm_16163_23_23617548</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CF464E10-1D06-4F7A-8780-67378F499DB8</gtr:id><gtr:title>Maximising value from a United Kingdom Biomedical Research Centre: study protocol.</gtr:title><gtr:parentPublicationTitle>Health research policy and systems</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/beed982914227a0221c1916225095a78"><gtr:id>beed982914227a0221c1916225095a78</gtr:id><gtr:otherNames>Greenhalgh T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1478-4505</gtr:issn><gtr:outcomeId>5a6f2f094d29f8.44133910</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CF65E618-EAB1-4169-B4EE-3538B7E76AE1</gtr:id><gtr:title>Clinical trial design: horses for courses.</gtr:title><gtr:parentPublicationTitle>World psychiatry : official journal of the World Psychiatric Association (WPA)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9ebafe692a2a37a88520983f3a8877a2"><gtr:id>9ebafe692a2a37a88520983f3a8877a2</gtr:id><gtr:otherNames>Geddes JR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1723-8617</gtr:issn><gtr:outcomeId>phDy8Z2k39s</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B1BAAB29-BA0B-448F-833C-B74B7B07AADF</gtr:id><gtr:title>Comparative evaluation of quetiapine plus lamotrigine combination versus quetiapine monotherapy (and folic acid versus placebo) in bipolar depression (CEQUEL): a 2 &amp;times; 2 factorial randomised trial.</gtr:title><gtr:parentPublicationTitle>The lancet. Psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9ebafe692a2a37a88520983f3a8877a2"><gtr:id>9ebafe692a2a37a88520983f3a8877a2</gtr:id><gtr:otherNames>Geddes JR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2215-0366</gtr:issn><gtr:outcomeId>56df4c566e6c14.68702046</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D207A42E-ED5A-4BAB-875F-347434528ED3</gtr:id><gtr:title>Treatment of bipolar disorder.</gtr:title><gtr:parentPublicationTitle>Lancet (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9ebafe692a2a37a88520983f3a8877a2"><gtr:id>9ebafe692a2a37a88520983f3a8877a2</gtr:id><gtr:otherNames>Geddes JR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0140-6736</gtr:issn><gtr:outcomeId>pm_16163_23_23663953</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>289A4E7D-20A6-40F2-AD79-6E6D83FB4455</gtr:id><gtr:title>Lamotrigine for treatment of bipolar depression: independent meta-analysis and meta-regression of individual patient data from five randomised trials.</gtr:title><gtr:parentPublicationTitle>The British journal of psychiatry : the journal of mental science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9ebafe692a2a37a88520983f3a8877a2"><gtr:id>9ebafe692a2a37a88520983f3a8877a2</gtr:id><gtr:otherNames>Geddes JR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0007-1250</gtr:issn><gtr:outcomeId>20293B06495</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>28346F9F-E456-4D3C-909C-BE9F19C879CB</gtr:id><gtr:title>The longitudinal course of bipolar disorder as revealed through weekly text messaging: a feasibility study.</gtr:title><gtr:parentPublicationTitle>Bipolar disorders</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c7d763669c0307c279836c62d4f0ee56"><gtr:id>c7d763669c0307c279836c62d4f0ee56</gtr:id><gtr:otherNames>Bopp JM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1398-5647</gtr:issn><gtr:outcomeId>qy2QvAv79Rj</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CD9B94E2-0D82-4571-AEB3-6445DF2BDA25</gtr:id><gtr:title>Pharmacological interventions for the prevention of relapse in bipolar disorder: a systematic review of controlled trials.</gtr:title><gtr:parentPublicationTitle>Journal of psychopharmacology (Oxford, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f203453fe8c1b7becbeb75514d58d26e"><gtr:id>f203453fe8c1b7becbeb75514d58d26e</gtr:id><gtr:otherNames>Beynon S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0269-8811</gtr:issn><gtr:outcomeId>5F85D43548B</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6F9805ED-DA87-4905-A91E-4AFFDAC0D4DE</gtr:id><gtr:title>Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis.</gtr:title><gtr:parentPublicationTitle>Lancet (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a112c692b6911db0d25f1d6fe8687c46"><gtr:id>a112c692b6911db0d25f1d6fe8687c46</gtr:id><gtr:otherNames>Leucht S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0140-6736</gtr:issn><gtr:outcomeId>pm_16163_23_23810019</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E4D26F14-6A08-4BE5-8F23-7E28901F60E6</gtr:id><gtr:title>Olanzapine in the long-term treatment of bipolar disorder: a systematic review and meta-analysis.</gtr:title><gtr:parentPublicationTitle>Journal of psychopharmacology (Oxford, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ae03b4213b5993d6847e1f0297848852"><gtr:id>ae03b4213b5993d6847e1f0297848852</gtr:id><gtr:otherNames>Cipriani A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0269-8811</gtr:issn><gtr:outcomeId>8E3609D1FB5</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8BF027FC-0E04-4204-A717-7DC4D18A52B2</gtr:id><gtr:title>Evidence-based guidelines for treating bipolar disorder: revised second edition--recommendations from the British Association for Psychopharmacology.</gtr:title><gtr:parentPublicationTitle>Journal of psychopharmacology (Oxford, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c15e111b142ba9fa72a41273b026519d"><gtr:id>c15e111b142ba9fa72a41273b026519d</gtr:id><gtr:otherNames>Goodwin GM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0269-8811</gtr:issn><gtr:outcomeId>B5EFD6D4D79</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>750EB26A-0DE1-4167-853C-79AE75B8C626</gtr:id><gtr:title>What is a randomised controlled trial?</gtr:title><gtr:parentPublicationTitle>Epidemiologia e psichiatria sociale</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ae03b4213b5993d6847e1f0297848852"><gtr:id>ae03b4213b5993d6847e1f0297848852</gtr:id><gtr:otherNames>Cipriani A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1121-189X</gtr:issn><gtr:outcomeId>bSFS1QmN2YG</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C3FADB65-548C-4FB6-9717-CD17B7FD0397</gtr:id><gtr:title>Cognitive functioning in patients with affective disorders and schizophrenia: a meta-analysis.</gtr:title><gtr:parentPublicationTitle>International review of psychiatry (Abingdon, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f0309933c4a85e9bded65685781388b3"><gtr:id>f0309933c4a85e9bded65685781388b3</gtr:id><gtr:otherNames>Stefanopoulou E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0954-0261</gtr:issn><gtr:outcomeId>AZAXmh8R1F7</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7D986470-2317-4E5E-8B4E-B9E23C0D4451</gtr:id><gtr:title>Lithium in the prevention of suicide in mood disorders: updated systematic review and meta-analysis.</gtr:title><gtr:parentPublicationTitle>BMJ (Clinical research ed.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ae03b4213b5993d6847e1f0297848852"><gtr:id>ae03b4213b5993d6847e1f0297848852</gtr:id><gtr:otherNames>Cipriani A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0959-535X</gtr:issn><gtr:outcomeId>pm_16163_23_23814104</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C0ABE7D0-FF0C-4306-B52F-409534D240B0</gtr:id><gtr:title>Meta-analysis, database, and meta-regression of 98 structural imaging studies in bipolar disorder.</gtr:title><gtr:parentPublicationTitle>Archives of general psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/daa4c647b01e6d721cb1a042538cb586"><gtr:id>daa4c647b01e6d721cb1a042538cb586</gtr:id><gtr:otherNames>Kempton MJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0003-990X</gtr:issn><gtr:outcomeId>3DDC8AC03C5</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>71EAEE17-61F6-4426-AD4A-8A8728C7CAC1</gtr:id><gtr:title>Common and specific elements of psychosocial treatments for bipolar disorder: a survey of clinicians participating in randomized trials.</gtr:title><gtr:parentPublicationTitle>Journal of psychiatric practice</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/413fce3f9b0332426c83eee1c246d06b"><gtr:id>413fce3f9b0332426c83eee1c246d06b</gtr:id><gtr:otherNames>Miklowitz DJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1527-4160</gtr:issn><gtr:outcomeId>453E8E492E2</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0700477</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>3C193D18-12BD-4B15-8347-037BA623E0FF</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Mental Health</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>7135039D-2DB0-4D41-87B3-FA1C8D38E133</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>6.1  Pharmaceuticals</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>